Literature DB >> 11579245

Viral load as an independent risk factor for opportunistic infections in HIV-infected adults and adolescents.

J E Kaplan1, D L Hanson, J L Jones, M S Dworkin.   

Abstract

OBJECTIVE: We investigated whether HIV plasma RNA (viral load; VL) predicts risk for opportunistic infections (OI) in HIV-infected persons, independent of CD4 lymphocyte count and other factors that might affect disease outcome.
METHODS: Among persons who had initiated antiretroviral therapy (ART), we studied the risk for OI following a VL measurement in the Centers for Disease Control and Prevention Adult and Adolescent Spectrum of HIV Disease (ASD) Project, a medical record review study of HIV-infected persons in 11 US cities. Analysis was limited to persons who had initiated ART and who had VL data, primarily from the period 1996-1999. Persons were considered at risk for OI for 1 to 6 months after a given VL; risk for OI was assessed using a Poisson multiple regression model controlling for CD4 lymphocyte count, ART, and other variables potentially associated with development of OI: history of AIDS OI, age, sex, race, HIV risk category, OI prophylaxis, and calendar year.
RESULTS: Although decreasing CD4 count was the strongest predictor of risk for OI [relative risk (RR), 13.3 for persons with CD4 lymphocyte count < 50 x 10(6)/l compared with persons with CD4 lymphocyte count > or = 500 x 10(6)/l], increasing VL was independently associated with increased risk [RR, 1.6, 1.9, 2.7, and 3.5 for VL of 7000-19 999, 20 000-54 999, 55 000-149 999, and > or = 150 000 copies/ml (by reverse transcription-PCR), respectively, compared with VL < 400]. Similar results were obtained when the risk period was reduced to 5, 4, 3, and 2 months after VL measurement.
CONCLUSIONS: VL is an independent risk factor for OI and should be considered in special situations, such as in decisions to discontinue primary or secondary OI prophylaxis after CD4 lymphocyte counts have increased in response to ART.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11579245     DOI: 10.1097/00002030-200109280-00012

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  17 in total

Review 1.  Update on opportunistic infections in the era of effective antiretroviral therapy.

Authors:  Brian C Zanoni; Rajesh T Gandhi
Journal:  Infect Dis Clin North Am       Date:  2014-09       Impact factor: 5.982

2.  Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010.

Authors:  Kate Buchacz; Bryan Lau; Yuezhou Jing; Ronald Bosch; Alison G Abraham; M John Gill; Michael J Silverberg; James J Goedert; Timothy R Sterling; Keri N Althoff; Jeffrey N Martin; Greer Burkholder; Neel Gandhi; Hasina Samji; Pragna Patel; Anita Rachlis; Jennifer E Thorne; Sonia Napravnik; Keith Henry; Angel Mayor; Kelly Gebo; Stephen J Gange; Richard D Moore; John T Brooks
Journal:  J Infect Dis       Date:  2016-04-18       Impact factor: 5.226

3.  Direct relationship between suppression of virus-specific immunity and emergence of cytomegalovirus disease in simian AIDS.

Authors:  Amitinder Kaur; Nadine Kassis; Corrina L Hale; Meredith Simon; Michelle Elliott; Alicia Gomez-Yafal; Jeffrey D Lifson; Ronald C Desrosiers; Fred Wang; Peter Barry; Michael Mach; R Paul Johnson
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 4.  Discontinuation of Pneumocystis jirovecii pneumonia prophylaxis with CD4 count <200 cells/µL and virologic suppression: a systematic review.

Authors:  Cecilia T Costiniuk; Dean A Fergusson; Steve Doucette; Jonathan B Angel
Journal:  PLoS One       Date:  2011-12-16       Impact factor: 3.240

5.  Viral load responses to HAART is an independent predictor of a new AIDS event in late stage HIV infected patients: prospective cohort study.

Authors:  Powel Kazanjian; Wei Wei; Morton Brown; Tejal Gandhi; Kamal Amin
Journal:  J Transl Med       Date:  2005-10-31       Impact factor: 5.531

6.  Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study.

Authors:  Ronnie Kasirye; Heiner Grosskurth; Paula Munderi; Jonathan Levin; Zacchaeus Anywaine; Andrew Nunn; Anatoli Kamali; Kathy Baisley
Journal:  Malar J       Date:  2016-07-15       Impact factor: 2.979

7.  HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies.

Authors:  Lukas Fenner; Andrew Atkinson; Andrew Boulle; Matthew P Fox; Hans Prozesky; Kathrin Zürcher; Marie Ballif; Hansjakob Furrer; Marcel Zwahlen; Mary-Ann Davies; Matthias Egger
Journal:  J Int AIDS Soc       Date:  2017-06-23       Impact factor: 5.396

Review 8.  Pneumocystis Pneumonia in Human Immunodeficiency Virus-infected Adults and Adolescents: Current Concepts and Future Directions.

Authors:  Sadatomo Tasaka
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-08-12

9.  Superior Effects of Antiretroviral Treatment among Men Who have Sex with Men Compared to Other HIV At-Risk Populations in a Large Cohort Study in Hunan, China.

Authors:  Shu Su; Xi Chen; Limin Mao; Jianmei He; Xiuqing Wei; Jun Jing; Lei Zhang
Journal:  Int J Environ Res Public Health       Date:  2016-03-08       Impact factor: 3.390

Review 10.  HIV-Associated TB Syndemic: A Growing Clinical Challenge Worldwide.

Authors:  Maria Theresa Montales; Arun Chaudhury; Alexandria Beebe; Sowmya Patil; Naveen Patil
Journal:  Front Public Health       Date:  2015-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.